We have collected information regarding stocks with the highest payout ratio so far. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. Chubb Corporation
60.71% Payout Ratio
Chubb Limited, through its subsidiaries, provides insurance and reinsurance products worldwide.
As claimed by Morningstar, Inc., the next dividend payment is on Dec 16, 2020, the estimated forward annual dividend rate is 3.12 and the estimated forward annual dividend yield is 1.99%.
Chubb Corporation's sales growth this year is anticipated to be 4.8% and 5.5% for next year.
Year-on-year quarterly revenue growth grew by 5%, now sitting on 34.92B for the twelve trailing months.
Chubb Corporation's sales growth is 5.4% for the present current quarter and 4.6% for the next. The company's growth estimates for the ongoing quarter and the next is 23.2% and 7.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.12%.
Volatility
Chubb Corporation's last day, last week, and last month's average volatility was a negative 0.72%, a positive 0.53%, and a positive 0.11%, respectively.
Chubb Corporation's last day, last week, and last month's high and low average amplitude percentage was 1.79%, 2.66%, and 1.91%, respectively.
Chubb Corporation's Stock Yearly Top and Bottom Value
Chubb Corporation's stock is valued at $155.86 at 16:23 EST, under its 52-week high of $167.74 and way above its 52-week low of $87.35.
Chubb Corporation's Moving Average
Chubb Corporation's value is above its 50-day moving average of $151.99 and way higher than its 200-day moving average of $133.00.
2. GAMCO Natural Resources, Gold & Income Trust
483.33% Payout Ratio
GAMCO Natural Resources, Gold & Income Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC.
As claimed by Morningstar, Inc., the next dividend payment is on Jan 12, 2021, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 6.74%.
GAMCO Natural Resources, Gold & Income Trust's sales growth this year is expected to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0%, now sitting on N/A for the twelve trailing months.
Volatility
GAMCO Natural Resources, Gold & Income Trust's last day, last week, and last month's average volatility was 1.33%, 0.97%, and 0.16%, respectively.
GAMCO Natural Resources, Gold & Income Trust's last day, last week, and last month's high and low average amplitude percentage was 1.71%, 1.78%, and 1.44%, respectively.
GAMCO Natural Resources, Gold & Income Trust's Stock Yearly Top and Bottom Value
GAMCO Natural Resources, Gold & Income Trust's stock is valued at $5.19 at 16:23 EST, way under its 52-week high of $6.19 and way above its 52-week low of $2.28.
GAMCO Natural Resources, Gold & Income Trust's Moving Average
GAMCO Natural Resources, Gold & Income Trust's value is higher than its 50-day moving average of $5.09 and higher than its 200-day moving average of $5.02.
3. Assurant, Inc.
37.39% Payout Ratio
Assurant, Inc., together with its subsidiaries, provides lifestyle and housing solutions that support, protect, and connect consumer purchases in North America, Latin America, Europe, and the Asia Pacific.
As maintained by Morningstar, Inc., the next dividend payment is on Nov 26, 2020, the estimated forward annual dividend rate is 2.64 and the estimated forward annual dividend yield is 1.91%.
Assurant, Inc.'s sales growth this year is expected to be 0.4% and 7.2% for next year.
Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 10.11B for the twelve trailing months.
Assurant, Inc.'s sales growth is negative 2.4% for the ongoing quarter and 2.7% for the next. The company's growth estimates for the ongoing quarter and the next is negative 6.2% and 2.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.44%.
Volatility
Assurant, Inc.'s last day, last week, and last month's average volatility was 4.39%, 0.81%, and 0.19%, respectively.
Assurant, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 4.27%, 2.77%, and 1.88%, respectively.
Assurant, Inc.'s Stock Yearly Top and Bottom Value
Assurant, Inc.'s stock is valued at $139.86 at 16:23 EST, below its 52-week high of $142.61 and way above its 52-week low of $76.27.
Assurant, Inc.'s Moving Average
Assurant, Inc.'s worth is above its 50-day moving average of $133.00 and way higher than its 200-day moving average of $121.36.
4. Columbia Seligman Premium Technology Growth Fund Inc
65.14% Payout Ratio
Columbia Seligman Premium Technology Growth Fund is a closed ended equity mutual fund launched and managed by Columbia Management Investment Advisers, LLC.
According to Morningstar, Inc., the next dividend payment is on May 10, 2018, the estimated forward annual dividend rate is 1.85 and the estimated forward annual dividend yield is 6.7%.
Columbia Seligman Premium Technology Growth Fund Inc's sales growth this year is anticipated to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0%, now sitting on N/A for the twelve trailing months.
Volatility
Columbia Seligman Premium Technology Growth Fund Inc's last day, last week, and last month's average volatility was 1.30%, 0.53%, and 0.20%, respectively.
Columbia Seligman Premium Technology Growth Fund Inc's last day, last week, and last month's high and low average amplitude percentage was 1.16%, 2.09%, and 1.56%, respectively.
Columbia Seligman Premium Technology Growth Fund Inc's Stock Yearly Top and Bottom Value
Columbia Seligman Premium Technology Growth Fund Inc's stock is valued at $27.96 at 16:23 EST, below its 52-week high of $28.01 and way higher than its 52-week low of $13.50.
Columbia Seligman Premium Technology Growth Fund Inc's Moving Average
Columbia Seligman Premium Technology Growth Fund Inc's worth is above its 50-day moving average of $26.67 and way higher than its 200-day moving average of $23.52.
Comp En De Mn Cemig ADS's last day, last week, and last month's average volatility was a negative 6.64%, a negative 1.12%, and a positive 0.06%, respectively.
Comp En De Mn Cemig ADS's last day, last week, and last month's high and low average amplitude percentage was 5.54%, 5.94%, and 3.65%, respectively.
Comp En De Mn Cemig ADS's Stock Yearly Top and Bottom Value
Comp En De Mn Cemig ADS's stock is valued at $2.71 at 16:23 EST, way under its 52-week high of $3.75 and way above its 52-week low of $1.28.
Comp En De Mn Cemig ADS's Moving Average
Comp En De Mn Cemig ADS's value is higher than its 50-day moving average of $2.64 and way higher than its 200-day moving average of $2.21.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.